Table 1.
Patient Characteristics
| Entire Cohort | |
|---|---|
| No. patients | 721 |
| Age, yrs | |
| Range | 41-91 |
| Mean | 70 |
| Gleason score | |
| 5 | 5 (< 1%) |
| 6 | 89 (12%) |
| 7 | 332 (46%) |
| 8 | 135 (18%) |
| 9 | 127 (18%) |
| 10 | 9 (1%) |
| Unknown | 24 (3%) |
| Prior Treatment | |
| Prostatectomy | 213 (30%) |
| Duration since treatment (yrs) | |
| Range | 0.2-27 |
| Mean/median | 5.98/4 |
| Radiation* | 251 (35%) |
| Duration since treatment (yrs) | |
| Range | 0.3-23 |
| Mean/median | 6.86/6 |
| Prostatectomy + Radiation** | 229 (32%) |
| Duration since treatment (yrs) | |
| Range | 0.2-27 |
| Mean/median | 8.8/7 |
| ADT¥ | 18 (2%) |
| Cyrotherapy | 5 (< 1%) |
| HIFUΩ | 5 (< 1%) |
| PSA at imaging, ng/mL | |
| Range | 0.22-148 |
| Mean/median | 5.9/2.6 |
| PSA Doubling Time, months | |
| Range | 0.2-151 |
| Mean/median | 6.7/4.24 |
| PSA Velocity, ng/mL/yr | |
| Range | 0.01-34.4 |
| Mean/median | 0.68/0.22 |
*
External beam radiation and/or Brachytherapy.
**
Adjuvant or Salvage external beam radiation.
¥
Androgen Deprivation Therapy.
Ω
High Intensity Focused Ultrasound.